Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Frontiers in Immunology
|
February 10, 2022
B-Cell Dysregulation in Idiopathic Nephrotic Syndrome: What We Know and What We Need to Discover
Manuela Colucci, Julie Oniszczuk, Marina Vivarelli, et al.
Nephrologie & Therapeutique
|
May 1, 2018
[Current insights about recurrence of glomerular diseases after renal transplantation]
Tomek Kofman, Julie Oniszczuk, Philippe Lang, et al.
Clinical Kidney Journal
|
February 25, 2022
<i>De novo</i> IgA vasculitis following adenovirus-based SARS-CoV-2 vaccination
Julie Oniszczuk, Thomas Bettuzzi, Louis Anjou, et al.
Kidney International
|
August 2, 2021
Scleroderma renal crisis following mRNA vaccination against SARS-CoV-2
Julie Oniszczuk, Eléonore Pagot, Nicolas Limal, et al.
Colloids and Surfaces. B, Biointerfaces
|
April 7, 2019
Cationic poly(cyclodextrin)/alginate nanocapsules: From design to application as efficient delivery vehicle of 4-hydroxy tamoxifen to podocyte in vitro
Sabrina Belbekhouche, Julie Oniszczuk, André Pawlak, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 9, 2017
Nephrotic Syndrome in Small Cell Lung Cancer and Induction of C-Mip in Podocytes
Yassine Bouatou, Thibaud Koessler, Julie Oniszczuk, et al.
QJM : Monthly Journal of the Association of Physicians
|
February 7, 2023
IgG4-related disease and small lymphocytic lymphoma
Anissa Moktefi, Sébastien Mulé, Nizar Joher, et al.
Journal of Clinical Medicine
|
November 15, 2018
Rituximab and Fibrillary Glomerulonephritis: Interest of B Cell Reconstitution Monitoring
Claire Leibler, Anissa Moktefi, Marie Matignon, et al.
Plos One
|
November 16, 2018
Expression of CMIP in podocytes is restricted to specific classes of lupus nephritis
Khedidja Bouachi, Anissa Moktefi, Shao-Yu Zhang, et al.
Journal of Autoimmunity
|
October 24, 2017
NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome
Ahmed Boumediene, Pauline Vachin, Kelhia Sendeyo, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Frontiers in Immunology
|
February 10, 2022
B-Cell Dysregulation in Idiopathic Nephrotic Syndrome: What We Know and What We Need to Discover
Manuela Colucci, Julie Oniszczuk, Marina Vivarelli, et al.
Nephrologie & Therapeutique
|
May 1, 2018
[Current insights about recurrence of glomerular diseases after renal transplantation]
Tomek Kofman, Julie Oniszczuk, Philippe Lang, et al.
Clinical Kidney Journal
|
February 25, 2022
<i>De novo</i> IgA vasculitis following adenovirus-based SARS-CoV-2 vaccination
Julie Oniszczuk, Thomas Bettuzzi, Louis Anjou, et al.
Kidney International
|
August 2, 2021
Scleroderma renal crisis following mRNA vaccination against SARS-CoV-2
Julie Oniszczuk, Eléonore Pagot, Nicolas Limal, et al.
Colloids and Surfaces. B, Biointerfaces
|
April 7, 2019
Cationic poly(cyclodextrin)/alginate nanocapsules: From design to application as efficient delivery vehicle of 4-hydroxy tamoxifen to podocyte in vitro
Sabrina Belbekhouche, Julie Oniszczuk, André Pawlak, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 9, 2017
Nephrotic Syndrome in Small Cell Lung Cancer and Induction of C-Mip in Podocytes
Yassine Bouatou, Thibaud Koessler, Julie Oniszczuk, et al.
QJM : Monthly Journal of the Association of Physicians
|
February 7, 2023
IgG4-related disease and small lymphocytic lymphoma
Anissa Moktefi, Sébastien Mulé, Nizar Joher, et al.
Journal of Clinical Medicine
|
November 15, 2018
Rituximab and Fibrillary Glomerulonephritis: Interest of B Cell Reconstitution Monitoring
Claire Leibler, Anissa Moktefi, Marie Matignon, et al.
Plos One
|
November 16, 2018
Expression of CMIP in podocytes is restricted to specific classes of lupus nephritis
Khedidja Bouachi, Anissa Moktefi, Shao-Yu Zhang, et al.
Journal of Autoimmunity
|
October 24, 2017
NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome
Ahmed Boumediene, Pauline Vachin, Kelhia Sendeyo, et al.
Page
of 3